| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 2 |
| 1 | LAMIVUDINE ORAL | 2 |
| 2 | ZIDOVUDINE | 2 |
| 3 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 |
| 4 | IMIQUIMOD | 1 |
| 5 | NEOMYCIN SULFATE | 1 |
| 6 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 1 | 0.0114 |
| 1 | GRANULOCYTE COLONY STIMULATING FACTOR | 1 | 0.0005 |
| 2 | IMIQUIMOD | 1 | 0.0004 |
| 3 | NEOMYCIN SULFATE | 1 | 0.0004 |
| 4 | ZIDOVUDINE | 2 | 0.0002 |
| 5 | LAMIVUDINE | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |